|Articles|September 15, 2020

How Has the COVID-19 Response Impacted People Living in Slum Neighborhoods?

Lockdowns implemented for pandemic control have broad health, social, and economic consequences. This is especially true for people who live and work in slum communities around the world.

Lockdowns implemented for pandemic control have broad health, social, and economic consequences. This is especially true for people who live and work in slum communities around the world.

As seen in a new study published in BMJ Global Health, direct stakeholder perspectives can shine a light on the matter. Investigators compared survey data from across 7 slums in Kenya, Nigeria, Bangladesh, and Pakistan gathered between March 2018 and May 2020.

The 860 survey respondents were community leaders, slum residents, health care workers, and local health authorities.

Normal health burdens across all sites included respiratory, gastric, waterborne and mosquitoborne illnesses and hypertension.

“Before the coronavirus pandemic, stakeholders identified preventive, diagnostic and treatment services, including well-used antenatal and immunization programs and screening for hypertension, tuberculosis, HIV and vector-borne disease,” according to study authors.

Afterward, that limited support evaporated.

With the advent of COVID-19 associated restrictions, a reduction in access to healthcare services was reported in all sites, including preventive services.

Cost of healthcare increased as household income was reduced. Residents also reported difficulty reaching health care facilities due to border controls and other restrictions.

Fear of being diagnosed with COVID-19 also discouraged healthcare seeking, according to respondents.

While telehealth and philanthropic support assisted, these were inconsistent and inadequate. There was no serious long-term support structure put in place for the world’s slums as health care systems and governments evacuated limited existing services.

The authors conclude that slum residents’ ability to seek health care for non-COVID-19 conditions has been dramatically reduced during lockdowns. Clear communication about risk, infection control services, and the import of other health burdens is necessary as fear of COVID-19 continues to drive treatment seeking behavior downwards.


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.